These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15490430)

  • 61. Confidence intervals for the difference in paired Youden indices.
    Zhou H; Qin G
    Pharm Stat; 2013; 12(1):17-27. PubMed ID: 23090764
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A cost-effectiveness analysis of aspirin versus oral anticoagulants after acute myocardial infarction in Italy -- equivalence of costs as a possible case for oral anticoagulants.
    Gianetti J; Gensini G; De Caterina R
    Thromb Haemost; 1998 Dec; 80(6):887-93. PubMed ID: 9869155
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Confidence intervals for distinguishing ordinal and disordinal interactions in multiple regression.
    Lee S; Lei MK; Brody GH
    Psychol Methods; 2015 Jun; 20(2):245-58. PubMed ID: 25844629
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Tolerance limits and tolerance intervals for ratios of normal random variables using a bootstrap calibration.
    Flouri M; Zhai S; Mathew T; Bebu I
    Biom J; 2017 May; 59(3):550-566. PubMed ID: 28181281
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Pointwise confidence intervals for a survival distribution with small samples or heavy censoring.
    Fay MP; Brittain EH; Proschan MA
    Biostatistics; 2013 Sep; 14(4):723-36. PubMed ID: 23632624
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Studentized bootstrap model-averaged tail area intervals.
    Zeng J; Fletcher D; Dillingham PW; Cornwall CE
    PLoS One; 2019; 14(3):e0213715. PubMed ID: 30883568
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Utilizing propensity scores to estimate causal treatment effects with censored time-lagged data.
    Anstrom KJ; Tsiatis AA
    Biometrics; 2001 Dec; 57(4):1207-18. PubMed ID: 11764262
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Bootstrap estimation of diagnostic accuracy with patient-clustered data.
    Rutter CM
    Acad Radiol; 2000 Jun; 7(6):413-9. PubMed ID: 10845400
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Bootstrap confidence intervals for cost-effectiveness ratios: some simulation results.
    Tambour M; Zethraeus N
    Health Econ; 1998 Mar; 7(2):143-7. PubMed ID: 9565170
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A note on confidence limits for quartiles with right censored data.
    Elashoff RM; Lee JJ; Afifi AA
    Stat Med; 1989 Oct; 8(10):1269-76. PubMed ID: 2814074
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Joint modeling of medical cost and survival in complex sample surveys.
    Xu H; Daggy J; Yu D; Craig BA; Sands L
    Stat Med; 2013 Apr; 32(9):1509-23. PubMed ID: 23023654
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Method of medians for lifetime data with Weibull models.
    He X; Fung WK
    Stat Med; 1999 Aug; 18(15):1993-2009. PubMed ID: 10440882
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Net-benefit regression with censored cost-effectiveness data from randomized or observational studies.
    Chen S; Hoch JS
    Stat Med; 2022 Sep; 41(20):3958-3974. PubMed ID: 35665527
    [TBL] [Abstract][Full Text] [Related]  

  • 74. On estimators of medical costs with censored data.
    O'Hagan A; Stevens JW
    J Health Econ; 2004 May; 23(3):615-25. PubMed ID: 15120473
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Estimating mean response as a function of treatment duration in an observational study, where duration may be informatively censored.
    Johnson BA; Tsiatis AA
    Biometrics; 2004 Jun; 60(2):315-23. PubMed ID: 15180656
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Analysis of cost data in randomized trials: an application of the non-parametric bootstrap.
    Barber JA; Thompson SG
    Stat Med; 2000 Dec; 19(23):3219-36. PubMed ID: 11113956
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Censored functional data for incomplete follow-up studies.
    Strzalkowska-Kominiak E; Romo J
    Stat Med; 2021 May; 40(12):2821-2838. PubMed ID: 33687096
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cost analysis with censored data.
    Huang Y
    Med Care; 2009 Jul; 47(7 Suppl 1):S115-9. PubMed ID: 19536024
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Confidence interval estimation for the changepoint of treatment stratification in the presence of a qualitative covariate-treatment interaction.
    Haller B; Mansmann U; Dobler D; Ulm K; Hapfelmeier A
    Stat Med; 2020 Jan; 39(1):70-96. PubMed ID: 31701549
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The distribution of genetic parameter estimates and confidence intervals from small disconnected diallels.
    Isik F; Boos DD; Li B
    Theor Appl Genet; 2005 May; 110(7):1236-43. PubMed ID: 15754206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.